Page 3 - Gel Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aerovate Therapeutics (NASDAQ:AVTE – Get Free Report) and Sol-Gel Technologies (NASDAQ:SLGL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Volatility & Risk Aerovate Therapeutics has a […]

Event to be held on December 6, 2023 will focus on preventing basal cell carcinomas associated with Gorlin syndrome with a discussion of the disease...

Event to be held on December 6, 2023 will focus on preventing basal cell carcinomas associated with Gorlin syndrome with a discussion of the disease burden, SGT-610 and the upcoming Phase 3 trial NESS ZIONA, Israel, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (Nasdaq: SLGL) (“Sol-Gel”), a dermatology company leveraging innovative approaches to develop pioneering treatments for patients with severe skin conditions, and with two approved large-category dermatology products, TWYNEO

Sol-Gel Technologies Ltd. (NASDAQ:SLGL – Get Free Report) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 59,200 shares, an increase of 16.5% from the September 30th total of 50,800 shares. Based on an average daily volume of 10,400 shares, the short-interest ratio […]

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...